Gilead Sciences said Wednesday that remdesivir, which has been authorized for emergency use since the spring, brought in $873 million in revenues so far this year.
Via https://www.nytimes.com/2020/10/29/health/covid-remdesivir-gilead.html
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. Archives
April 2023
Categories |